Medical Care
Global ADAM10 Antibody Market Research Report 2025
- May 12, 25
- ID: 234928
- Pages: 94
- Figures: 92
- Views: 5
The global market for ADAM10 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
ADAM10 Antibody is a mouse, rabbit, porcine and human antibody against ADAM10. ADAM10 was recognized in immunohistochemical staining and western blotting.
Growing patient base, launch of novel ADAM10 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ADAM10 antibody market revenue.
This report aims to provide a comprehensive presentation of the global market for ADAM10 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADAM10 Antibody.
The ADAM10 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADAM10 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADAM10 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LifeSpan BioSciences
Thermo Fisher Scientific
QED Bioscience
BosterBio
NSJ Bioreagents
EpiGentek
GeneTex
Cell Signaling Technology
RayBiotech
HUABIO
ProSci
Novus Biologicals
R and D Systems
Alomone Labs
Affinity Biosciences
Proteintech Group
Miltenyi Biotec
Enzo Life Sciences
Biobyt
Sino Biological
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ADAM10 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
ADAM10 Antibody is a mouse, rabbit, porcine and human antibody against ADAM10. ADAM10 was recognized in immunohistochemical staining and western blotting.
Growing patient base, launch of novel ADAM10 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ADAM10 antibody market revenue.
This report aims to provide a comprehensive presentation of the global market for ADAM10 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADAM10 Antibody.
The ADAM10 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADAM10 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADAM10 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LifeSpan BioSciences
Thermo Fisher Scientific
QED Bioscience
BosterBio
NSJ Bioreagents
EpiGentek
GeneTex
Cell Signaling Technology
RayBiotech
HUABIO
ProSci
Novus Biologicals
R and D Systems
Alomone Labs
Affinity Biosciences
Proteintech Group
Miltenyi Biotec
Enzo Life Sciences
Biobyt
Sino Biological
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ADAM10 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADAM10 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global ADAM10 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADAM10 Antibody Market Perspective (2020-2031)
2.2 Global ADAM10 Antibody Growth Trends by Region
2.2.1 Global ADAM10 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 ADAM10 Antibody Historic Market Size by Region (2020-2025)
2.2.3 ADAM10 Antibody Forecasted Market Size by Region (2026-2031)
2.3 ADAM10 Antibody Market Dynamics
2.3.1 ADAM10 Antibody Industry Trends
2.3.2 ADAM10 Antibody Market Drivers
2.3.3 ADAM10 Antibody Market Challenges
2.3.4 ADAM10 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADAM10 Antibody Players by Revenue
3.1.1 Global Top ADAM10 Antibody Players by Revenue (2020-2025)
3.1.2 Global ADAM10 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global ADAM10 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by ADAM10 Antibody Revenue
3.4 Global ADAM10 Antibody Market Concentration Ratio
3.4.1 Global ADAM10 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADAM10 Antibody Revenue in 2024
3.5 Global Key Players of ADAM10 Antibody Head office and Area Served
3.6 Global Key Players of ADAM10 Antibody, Product and Application
3.7 Global Key Players of ADAM10 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ADAM10 Antibody Breakdown Data by Type
4.1 Global ADAM10 Antibody Historic Market Size by Type (2020-2025)
4.2 Global ADAM10 Antibody Forecasted Market Size by Type (2026-2031)
5 ADAM10 Antibody Breakdown Data by Application
5.1 Global ADAM10 Antibody Historic Market Size by Application (2020-2025)
5.2 Global ADAM10 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America ADAM10 Antibody Market Size (2020-2031)
6.2 North America ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America ADAM10 Antibody Market Size by Country (2020-2025)
6.4 North America ADAM10 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADAM10 Antibody Market Size (2020-2031)
7.2 Europe ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe ADAM10 Antibody Market Size by Country (2020-2025)
7.4 Europe ADAM10 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADAM10 Antibody Market Size (2020-2031)
8.2 Asia-Pacific ADAM10 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific ADAM10 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific ADAM10 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADAM10 Antibody Market Size (2020-2031)
9.2 Latin America ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America ADAM10 Antibody Market Size by Country (2020-2025)
9.4 Latin America ADAM10 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADAM10 Antibody Market Size (2020-2031)
10.2 Middle East & Africa ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa ADAM10 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa ADAM10 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LifeSpan BioSciences
11.1.1 LifeSpan BioSciences Company Details
11.1.2 LifeSpan BioSciences Business Overview
11.1.3 LifeSpan BioSciences ADAM10 Antibody Introduction
11.1.4 LifeSpan BioSciences Revenue in ADAM10 Antibody Business (2020-2025)
11.1.5 LifeSpan BioSciences Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific ADAM10 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in ADAM10 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 QED Bioscience
11.3.1 QED Bioscience Company Details
11.3.2 QED Bioscience Business Overview
11.3.3 QED Bioscience ADAM10 Antibody Introduction
11.3.4 QED Bioscience Revenue in ADAM10 Antibody Business (2020-2025)
11.3.5 QED Bioscience Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Details
11.4.2 BosterBio Business Overview
11.4.3 BosterBio ADAM10 Antibody Introduction
11.4.4 BosterBio Revenue in ADAM10 Antibody Business (2020-2025)
11.4.5 BosterBio Recent Development
11.5 NSJ Bioreagents
11.5.1 NSJ Bioreagents Company Details
11.5.2 NSJ Bioreagents Business Overview
11.5.3 NSJ Bioreagents ADAM10 Antibody Introduction
11.5.4 NSJ Bioreagents Revenue in ADAM10 Antibody Business (2020-2025)
11.5.5 NSJ Bioreagents Recent Development
11.6 EpiGentek
11.6.1 EpiGentek Company Details
11.6.2 EpiGentek Business Overview
11.6.3 EpiGentek ADAM10 Antibody Introduction
11.6.4 EpiGentek Revenue in ADAM10 Antibody Business (2020-2025)
11.6.5 EpiGentek Recent Development
11.7 GeneTex
11.7.1 GeneTex Company Details
11.7.2 GeneTex Business Overview
11.7.3 GeneTex ADAM10 Antibody Introduction
11.7.4 GeneTex Revenue in ADAM10 Antibody Business (2020-2025)
11.7.5 GeneTex Recent Development
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Details
11.8.2 Cell Signaling Technology Business Overview
11.8.3 Cell Signaling Technology ADAM10 Antibody Introduction
11.8.4 Cell Signaling Technology Revenue in ADAM10 Antibody Business (2020-2025)
11.8.5 Cell Signaling Technology Recent Development
11.9 RayBiotech
11.9.1 RayBiotech Company Details
11.9.2 RayBiotech Business Overview
11.9.3 RayBiotech ADAM10 Antibody Introduction
11.9.4 RayBiotech Revenue in ADAM10 Antibody Business (2020-2025)
11.9.5 RayBiotech Recent Development
11.10 HUABIO
11.10.1 HUABIO Company Details
11.10.2 HUABIO Business Overview
11.10.3 HUABIO ADAM10 Antibody Introduction
11.10.4 HUABIO Revenue in ADAM10 Antibody Business (2020-2025)
11.10.5 HUABIO Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci ADAM10 Antibody Introduction
11.11.4 ProSci Revenue in ADAM10 Antibody Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Details
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals ADAM10 Antibody Introduction
11.12.4 Novus Biologicals Revenue in ADAM10 Antibody Business (2020-2025)
11.12.5 Novus Biologicals Recent Development
11.13 R and D Systems
11.13.1 R and D Systems Company Details
11.13.2 R and D Systems Business Overview
11.13.3 R and D Systems ADAM10 Antibody Introduction
11.13.4 R and D Systems Revenue in ADAM10 Antibody Business (2020-2025)
11.13.5 R and D Systems Recent Development
11.14 Alomone Labs
11.14.1 Alomone Labs Company Details
11.14.2 Alomone Labs Business Overview
11.14.3 Alomone Labs ADAM10 Antibody Introduction
11.14.4 Alomone Labs Revenue in ADAM10 Antibody Business (2020-2025)
11.14.5 Alomone Labs Recent Development
11.15 Affinity Biosciences
11.15.1 Affinity Biosciences Company Details
11.15.2 Affinity Biosciences Business Overview
11.15.3 Affinity Biosciences ADAM10 Antibody Introduction
11.15.4 Affinity Biosciences Revenue in ADAM10 Antibody Business (2020-2025)
11.15.5 Affinity Biosciences Recent Development
11.16 Proteintech Group
11.16.1 Proteintech Group Company Details
11.16.2 Proteintech Group Business Overview
11.16.3 Proteintech Group ADAM10 Antibody Introduction
11.16.4 Proteintech Group Revenue in ADAM10 Antibody Business (2020-2025)
11.16.5 Proteintech Group Recent Development
11.17 Miltenyi Biotec
11.17.1 Miltenyi Biotec Company Details
11.17.2 Miltenyi Biotec Business Overview
11.17.3 Miltenyi Biotec ADAM10 Antibody Introduction
11.17.4 Miltenyi Biotec Revenue in ADAM10 Antibody Business (2020-2025)
11.17.5 Miltenyi Biotec Recent Development
11.18 Enzo Life Sciences
11.18.1 Enzo Life Sciences Company Details
11.18.2 Enzo Life Sciences Business Overview
11.18.3 Enzo Life Sciences ADAM10 Antibody Introduction
11.18.4 Enzo Life Sciences Revenue in ADAM10 Antibody Business (2020-2025)
11.18.5 Enzo Life Sciences Recent Development
11.19 Biobyt
11.19.1 Biobyt Company Details
11.19.2 Biobyt Business Overview
11.19.3 Biobyt ADAM10 Antibody Introduction
11.19.4 Biobyt Revenue in ADAM10 Antibody Business (2020-2025)
11.19.5 Biobyt Recent Development
11.20 Sino Biological
11.20.1 Sino Biological Company Details
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological ADAM10 Antibody Introduction
11.20.4 Sino Biological Revenue in ADAM10 Antibody Business (2020-2025)
11.20.5 Sino Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADAM10 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global ADAM10 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADAM10 Antibody Market Perspective (2020-2031)
2.2 Global ADAM10 Antibody Growth Trends by Region
2.2.1 Global ADAM10 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 ADAM10 Antibody Historic Market Size by Region (2020-2025)
2.2.3 ADAM10 Antibody Forecasted Market Size by Region (2026-2031)
2.3 ADAM10 Antibody Market Dynamics
2.3.1 ADAM10 Antibody Industry Trends
2.3.2 ADAM10 Antibody Market Drivers
2.3.3 ADAM10 Antibody Market Challenges
2.3.4 ADAM10 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADAM10 Antibody Players by Revenue
3.1.1 Global Top ADAM10 Antibody Players by Revenue (2020-2025)
3.1.2 Global ADAM10 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global ADAM10 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by ADAM10 Antibody Revenue
3.4 Global ADAM10 Antibody Market Concentration Ratio
3.4.1 Global ADAM10 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADAM10 Antibody Revenue in 2024
3.5 Global Key Players of ADAM10 Antibody Head office and Area Served
3.6 Global Key Players of ADAM10 Antibody, Product and Application
3.7 Global Key Players of ADAM10 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ADAM10 Antibody Breakdown Data by Type
4.1 Global ADAM10 Antibody Historic Market Size by Type (2020-2025)
4.2 Global ADAM10 Antibody Forecasted Market Size by Type (2026-2031)
5 ADAM10 Antibody Breakdown Data by Application
5.1 Global ADAM10 Antibody Historic Market Size by Application (2020-2025)
5.2 Global ADAM10 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America ADAM10 Antibody Market Size (2020-2031)
6.2 North America ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America ADAM10 Antibody Market Size by Country (2020-2025)
6.4 North America ADAM10 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADAM10 Antibody Market Size (2020-2031)
7.2 Europe ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe ADAM10 Antibody Market Size by Country (2020-2025)
7.4 Europe ADAM10 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADAM10 Antibody Market Size (2020-2031)
8.2 Asia-Pacific ADAM10 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific ADAM10 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific ADAM10 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADAM10 Antibody Market Size (2020-2031)
9.2 Latin America ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America ADAM10 Antibody Market Size by Country (2020-2025)
9.4 Latin America ADAM10 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADAM10 Antibody Market Size (2020-2031)
10.2 Middle East & Africa ADAM10 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa ADAM10 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa ADAM10 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LifeSpan BioSciences
11.1.1 LifeSpan BioSciences Company Details
11.1.2 LifeSpan BioSciences Business Overview
11.1.3 LifeSpan BioSciences ADAM10 Antibody Introduction
11.1.4 LifeSpan BioSciences Revenue in ADAM10 Antibody Business (2020-2025)
11.1.5 LifeSpan BioSciences Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific ADAM10 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in ADAM10 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 QED Bioscience
11.3.1 QED Bioscience Company Details
11.3.2 QED Bioscience Business Overview
11.3.3 QED Bioscience ADAM10 Antibody Introduction
11.3.4 QED Bioscience Revenue in ADAM10 Antibody Business (2020-2025)
11.3.5 QED Bioscience Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Details
11.4.2 BosterBio Business Overview
11.4.3 BosterBio ADAM10 Antibody Introduction
11.4.4 BosterBio Revenue in ADAM10 Antibody Business (2020-2025)
11.4.5 BosterBio Recent Development
11.5 NSJ Bioreagents
11.5.1 NSJ Bioreagents Company Details
11.5.2 NSJ Bioreagents Business Overview
11.5.3 NSJ Bioreagents ADAM10 Antibody Introduction
11.5.4 NSJ Bioreagents Revenue in ADAM10 Antibody Business (2020-2025)
11.5.5 NSJ Bioreagents Recent Development
11.6 EpiGentek
11.6.1 EpiGentek Company Details
11.6.2 EpiGentek Business Overview
11.6.3 EpiGentek ADAM10 Antibody Introduction
11.6.4 EpiGentek Revenue in ADAM10 Antibody Business (2020-2025)
11.6.5 EpiGentek Recent Development
11.7 GeneTex
11.7.1 GeneTex Company Details
11.7.2 GeneTex Business Overview
11.7.3 GeneTex ADAM10 Antibody Introduction
11.7.4 GeneTex Revenue in ADAM10 Antibody Business (2020-2025)
11.7.5 GeneTex Recent Development
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Details
11.8.2 Cell Signaling Technology Business Overview
11.8.3 Cell Signaling Technology ADAM10 Antibody Introduction
11.8.4 Cell Signaling Technology Revenue in ADAM10 Antibody Business (2020-2025)
11.8.5 Cell Signaling Technology Recent Development
11.9 RayBiotech
11.9.1 RayBiotech Company Details
11.9.2 RayBiotech Business Overview
11.9.3 RayBiotech ADAM10 Antibody Introduction
11.9.4 RayBiotech Revenue in ADAM10 Antibody Business (2020-2025)
11.9.5 RayBiotech Recent Development
11.10 HUABIO
11.10.1 HUABIO Company Details
11.10.2 HUABIO Business Overview
11.10.3 HUABIO ADAM10 Antibody Introduction
11.10.4 HUABIO Revenue in ADAM10 Antibody Business (2020-2025)
11.10.5 HUABIO Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci ADAM10 Antibody Introduction
11.11.4 ProSci Revenue in ADAM10 Antibody Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Details
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals ADAM10 Antibody Introduction
11.12.4 Novus Biologicals Revenue in ADAM10 Antibody Business (2020-2025)
11.12.5 Novus Biologicals Recent Development
11.13 R and D Systems
11.13.1 R and D Systems Company Details
11.13.2 R and D Systems Business Overview
11.13.3 R and D Systems ADAM10 Antibody Introduction
11.13.4 R and D Systems Revenue in ADAM10 Antibody Business (2020-2025)
11.13.5 R and D Systems Recent Development
11.14 Alomone Labs
11.14.1 Alomone Labs Company Details
11.14.2 Alomone Labs Business Overview
11.14.3 Alomone Labs ADAM10 Antibody Introduction
11.14.4 Alomone Labs Revenue in ADAM10 Antibody Business (2020-2025)
11.14.5 Alomone Labs Recent Development
11.15 Affinity Biosciences
11.15.1 Affinity Biosciences Company Details
11.15.2 Affinity Biosciences Business Overview
11.15.3 Affinity Biosciences ADAM10 Antibody Introduction
11.15.4 Affinity Biosciences Revenue in ADAM10 Antibody Business (2020-2025)
11.15.5 Affinity Biosciences Recent Development
11.16 Proteintech Group
11.16.1 Proteintech Group Company Details
11.16.2 Proteintech Group Business Overview
11.16.3 Proteintech Group ADAM10 Antibody Introduction
11.16.4 Proteintech Group Revenue in ADAM10 Antibody Business (2020-2025)
11.16.5 Proteintech Group Recent Development
11.17 Miltenyi Biotec
11.17.1 Miltenyi Biotec Company Details
11.17.2 Miltenyi Biotec Business Overview
11.17.3 Miltenyi Biotec ADAM10 Antibody Introduction
11.17.4 Miltenyi Biotec Revenue in ADAM10 Antibody Business (2020-2025)
11.17.5 Miltenyi Biotec Recent Development
11.18 Enzo Life Sciences
11.18.1 Enzo Life Sciences Company Details
11.18.2 Enzo Life Sciences Business Overview
11.18.3 Enzo Life Sciences ADAM10 Antibody Introduction
11.18.4 Enzo Life Sciences Revenue in ADAM10 Antibody Business (2020-2025)
11.18.5 Enzo Life Sciences Recent Development
11.19 Biobyt
11.19.1 Biobyt Company Details
11.19.2 Biobyt Business Overview
11.19.3 Biobyt ADAM10 Antibody Introduction
11.19.4 Biobyt Revenue in ADAM10 Antibody Business (2020-2025)
11.19.5 Biobyt Recent Development
11.20 Sino Biological
11.20.1 Sino Biological Company Details
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological ADAM10 Antibody Introduction
11.20.4 Sino Biological Revenue in ADAM10 Antibody Business (2020-2025)
11.20.5 Sino Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global ADAM10 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global ADAM10 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global ADAM10 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global ADAM10 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global ADAM10 Antibody Market Share by Region (2020-2025)
Table 8. Global ADAM10 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global ADAM10 Antibody Market Share by Region (2026-2031)
Table 10. ADAM10 Antibody Market Trends
Table 11. ADAM10 Antibody Market Drivers
Table 12. ADAM10 Antibody Market Challenges
Table 13. ADAM10 Antibody Market Restraints
Table 14. Global ADAM10 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global ADAM10 Antibody Market Share by Players (2020-2025)
Table 16. Global Top ADAM10 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADAM10 Antibody as of 2024)
Table 17. Ranking of Global Top ADAM10 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by ADAM10 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of ADAM10 Antibody, Headquarters and Area Served
Table 20. Global Key Players of ADAM10 Antibody, Product and Application
Table 21. Global Key Players of ADAM10 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ADAM10 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global ADAM10 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global ADAM10 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global ADAM10 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global ADAM10 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global ADAM10 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global ADAM10 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global ADAM10 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific ADAM10 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific ADAM10 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific ADAM10 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. LifeSpan BioSciences Company Details
Table 47. LifeSpan BioSciences Business Overview
Table 48. LifeSpan BioSciences ADAM10 Antibody Product
Table 49. LifeSpan BioSciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 50. LifeSpan BioSciences Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific ADAM10 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. QED Bioscience Company Details
Table 57. QED Bioscience Business Overview
Table 58. QED Bioscience ADAM10 Antibody Product
Table 59. QED Bioscience Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 60. QED Bioscience Recent Development
Table 61. BosterBio Company Details
Table 62. BosterBio Business Overview
Table 63. BosterBio ADAM10 Antibody Product
Table 64. BosterBio Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 65. BosterBio Recent Development
Table 66. NSJ Bioreagents Company Details
Table 67. NSJ Bioreagents Business Overview
Table 68. NSJ Bioreagents ADAM10 Antibody Product
Table 69. NSJ Bioreagents Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 70. NSJ Bioreagents Recent Development
Table 71. EpiGentek Company Details
Table 72. EpiGentek Business Overview
Table 73. EpiGentek ADAM10 Antibody Product
Table 74. EpiGentek Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 75. EpiGentek Recent Development
Table 76. GeneTex Company Details
Table 77. GeneTex Business Overview
Table 78. GeneTex ADAM10 Antibody Product
Table 79. GeneTex Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 80. GeneTex Recent Development
Table 81. Cell Signaling Technology Company Details
Table 82. Cell Signaling Technology Business Overview
Table 83. Cell Signaling Technology ADAM10 Antibody Product
Table 84. Cell Signaling Technology Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 85. Cell Signaling Technology Recent Development
Table 86. RayBiotech Company Details
Table 87. RayBiotech Business Overview
Table 88. RayBiotech ADAM10 Antibody Product
Table 89. RayBiotech Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 90. RayBiotech Recent Development
Table 91. HUABIO Company Details
Table 92. HUABIO Business Overview
Table 93. HUABIO ADAM10 Antibody Product
Table 94. HUABIO Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 95. HUABIO Recent Development
Table 96. ProSci Company Details
Table 97. ProSci Business Overview
Table 98. ProSci ADAM10 Antibody Product
Table 99. ProSci Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 100. ProSci Recent Development
Table 101. Novus Biologicals Company Details
Table 102. Novus Biologicals Business Overview
Table 103. Novus Biologicals ADAM10 Antibody Product
Table 104. Novus Biologicals Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 105. Novus Biologicals Recent Development
Table 106. R and D Systems Company Details
Table 107. R and D Systems Business Overview
Table 108. R and D Systems ADAM10 Antibody Product
Table 109. R and D Systems Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 110. R and D Systems Recent Development
Table 111. Alomone Labs Company Details
Table 112. Alomone Labs Business Overview
Table 113. Alomone Labs ADAM10 Antibody Product
Table 114. Alomone Labs Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 115. Alomone Labs Recent Development
Table 116. Affinity Biosciences Company Details
Table 117. Affinity Biosciences Business Overview
Table 118. Affinity Biosciences ADAM10 Antibody Product
Table 119. Affinity Biosciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 120. Affinity Biosciences Recent Development
Table 121. Proteintech Group Company Details
Table 122. Proteintech Group Business Overview
Table 123. Proteintech Group ADAM10 Antibody Product
Table 124. Proteintech Group Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 125. Proteintech Group Recent Development
Table 126. Miltenyi Biotec Company Details
Table 127. Miltenyi Biotec Business Overview
Table 128. Miltenyi Biotec ADAM10 Antibody Product
Table 129. Miltenyi Biotec Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 130. Miltenyi Biotec Recent Development
Table 131. Enzo Life Sciences Company Details
Table 132. Enzo Life Sciences Business Overview
Table 133. Enzo Life Sciences ADAM10 Antibody Product
Table 134. Enzo Life Sciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 135. Enzo Life Sciences Recent Development
Table 136. Biobyt Company Details
Table 137. Biobyt Business Overview
Table 138. Biobyt ADAM10 Antibody Product
Table 139. Biobyt Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 140. Biobyt Recent Development
Table 141. Sino Biological Company Details
Table 142. Sino Biological Business Overview
Table 143. Sino Biological ADAM10 Antibody Product
Table 144. Sino Biological Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 145. Sino Biological Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. ADAM10 Antibody Picture
Figure 2. Global ADAM10 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global ADAM10 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global ADAM10 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global ADAM10 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. ADAM10 Antibody Report Years Considered
Figure 15. Global ADAM10 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global ADAM10 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global ADAM10 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global ADAM10 Antibody Market Share by Players in 2024
Figure 19. Global Top ADAM10 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADAM10 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by ADAM10 Antibody Revenue in 2024
Figure 21. North America ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America ADAM10 Antibody Market Share by Country (2020-2031)
Figure 23. United States ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe ADAM10 Antibody Market Share by Country (2020-2031)
Figure 27. Germany ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific ADAM10 Antibody Market Share by Region (2020-2031)
Figure 35. China ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America ADAM10 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa ADAM10 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. LifeSpan BioSciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 52. QED Bioscience Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 53. BosterBio Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 54. NSJ Bioreagents Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 55. EpiGentek Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 56. GeneTex Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 57. Cell Signaling Technology Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 58. RayBiotech Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 59. HUABIO Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 60. ProSci Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 61. Novus Biologicals Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 62. R and D Systems Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 63. Alomone Labs Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 64. Affinity Biosciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 65. Proteintech Group Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 66. Miltenyi Biotec Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 67. Enzo Life Sciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 68. Biobyt Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 69. Sino Biological Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global ADAM10 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global ADAM10 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global ADAM10 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global ADAM10 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global ADAM10 Antibody Market Share by Region (2020-2025)
Table 8. Global ADAM10 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global ADAM10 Antibody Market Share by Region (2026-2031)
Table 10. ADAM10 Antibody Market Trends
Table 11. ADAM10 Antibody Market Drivers
Table 12. ADAM10 Antibody Market Challenges
Table 13. ADAM10 Antibody Market Restraints
Table 14. Global ADAM10 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global ADAM10 Antibody Market Share by Players (2020-2025)
Table 16. Global Top ADAM10 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADAM10 Antibody as of 2024)
Table 17. Ranking of Global Top ADAM10 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by ADAM10 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of ADAM10 Antibody, Headquarters and Area Served
Table 20. Global Key Players of ADAM10 Antibody, Product and Application
Table 21. Global Key Players of ADAM10 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ADAM10 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global ADAM10 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global ADAM10 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global ADAM10 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global ADAM10 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global ADAM10 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global ADAM10 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global ADAM10 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific ADAM10 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific ADAM10 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific ADAM10 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa ADAM10 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa ADAM10 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa ADAM10 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. LifeSpan BioSciences Company Details
Table 47. LifeSpan BioSciences Business Overview
Table 48. LifeSpan BioSciences ADAM10 Antibody Product
Table 49. LifeSpan BioSciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 50. LifeSpan BioSciences Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific ADAM10 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. QED Bioscience Company Details
Table 57. QED Bioscience Business Overview
Table 58. QED Bioscience ADAM10 Antibody Product
Table 59. QED Bioscience Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 60. QED Bioscience Recent Development
Table 61. BosterBio Company Details
Table 62. BosterBio Business Overview
Table 63. BosterBio ADAM10 Antibody Product
Table 64. BosterBio Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 65. BosterBio Recent Development
Table 66. NSJ Bioreagents Company Details
Table 67. NSJ Bioreagents Business Overview
Table 68. NSJ Bioreagents ADAM10 Antibody Product
Table 69. NSJ Bioreagents Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 70. NSJ Bioreagents Recent Development
Table 71. EpiGentek Company Details
Table 72. EpiGentek Business Overview
Table 73. EpiGentek ADAM10 Antibody Product
Table 74. EpiGentek Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 75. EpiGentek Recent Development
Table 76. GeneTex Company Details
Table 77. GeneTex Business Overview
Table 78. GeneTex ADAM10 Antibody Product
Table 79. GeneTex Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 80. GeneTex Recent Development
Table 81. Cell Signaling Technology Company Details
Table 82. Cell Signaling Technology Business Overview
Table 83. Cell Signaling Technology ADAM10 Antibody Product
Table 84. Cell Signaling Technology Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 85. Cell Signaling Technology Recent Development
Table 86. RayBiotech Company Details
Table 87. RayBiotech Business Overview
Table 88. RayBiotech ADAM10 Antibody Product
Table 89. RayBiotech Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 90. RayBiotech Recent Development
Table 91. HUABIO Company Details
Table 92. HUABIO Business Overview
Table 93. HUABIO ADAM10 Antibody Product
Table 94. HUABIO Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 95. HUABIO Recent Development
Table 96. ProSci Company Details
Table 97. ProSci Business Overview
Table 98. ProSci ADAM10 Antibody Product
Table 99. ProSci Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 100. ProSci Recent Development
Table 101. Novus Biologicals Company Details
Table 102. Novus Biologicals Business Overview
Table 103. Novus Biologicals ADAM10 Antibody Product
Table 104. Novus Biologicals Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 105. Novus Biologicals Recent Development
Table 106. R and D Systems Company Details
Table 107. R and D Systems Business Overview
Table 108. R and D Systems ADAM10 Antibody Product
Table 109. R and D Systems Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 110. R and D Systems Recent Development
Table 111. Alomone Labs Company Details
Table 112. Alomone Labs Business Overview
Table 113. Alomone Labs ADAM10 Antibody Product
Table 114. Alomone Labs Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 115. Alomone Labs Recent Development
Table 116. Affinity Biosciences Company Details
Table 117. Affinity Biosciences Business Overview
Table 118. Affinity Biosciences ADAM10 Antibody Product
Table 119. Affinity Biosciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 120. Affinity Biosciences Recent Development
Table 121. Proteintech Group Company Details
Table 122. Proteintech Group Business Overview
Table 123. Proteintech Group ADAM10 Antibody Product
Table 124. Proteintech Group Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 125. Proteintech Group Recent Development
Table 126. Miltenyi Biotec Company Details
Table 127. Miltenyi Biotec Business Overview
Table 128. Miltenyi Biotec ADAM10 Antibody Product
Table 129. Miltenyi Biotec Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 130. Miltenyi Biotec Recent Development
Table 131. Enzo Life Sciences Company Details
Table 132. Enzo Life Sciences Business Overview
Table 133. Enzo Life Sciences ADAM10 Antibody Product
Table 134. Enzo Life Sciences Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 135. Enzo Life Sciences Recent Development
Table 136. Biobyt Company Details
Table 137. Biobyt Business Overview
Table 138. Biobyt ADAM10 Antibody Product
Table 139. Biobyt Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 140. Biobyt Recent Development
Table 141. Sino Biological Company Details
Table 142. Sino Biological Business Overview
Table 143. Sino Biological ADAM10 Antibody Product
Table 144. Sino Biological Revenue in ADAM10 Antibody Business (2020-2025) & (US$ Million)
Table 145. Sino Biological Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. ADAM10 Antibody Picture
Figure 2. Global ADAM10 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global ADAM10 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global ADAM10 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global ADAM10 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. ADAM10 Antibody Report Years Considered
Figure 15. Global ADAM10 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global ADAM10 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global ADAM10 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global ADAM10 Antibody Market Share by Players in 2024
Figure 19. Global Top ADAM10 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADAM10 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by ADAM10 Antibody Revenue in 2024
Figure 21. North America ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America ADAM10 Antibody Market Share by Country (2020-2031)
Figure 23. United States ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe ADAM10 Antibody Market Share by Country (2020-2031)
Figure 27. Germany ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific ADAM10 Antibody Market Share by Region (2020-2031)
Figure 35. China ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America ADAM10 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa ADAM10 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE ADAM10 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. LifeSpan BioSciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 52. QED Bioscience Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 53. BosterBio Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 54. NSJ Bioreagents Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 55. EpiGentek Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 56. GeneTex Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 57. Cell Signaling Technology Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 58. RayBiotech Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 59. HUABIO Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 60. ProSci Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 61. Novus Biologicals Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 62. R and D Systems Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 63. Alomone Labs Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 64. Affinity Biosciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 65. Proteintech Group Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 66. Miltenyi Biotec Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 67. Enzo Life Sciences Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 68. Biobyt Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 69. Sino Biological Revenue Growth Rate in ADAM10 Antibody Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232